Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Cash & Equivalents (2016 - 2025)

Pro Dex's Cash & Equivalents history spans 13 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 11950.0% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, up 11950.0%, while the annual FY2025 figure was $419000.0, 84.07% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $8.0 million at Pro Dex, up from $514000.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $8.0 million in Q4 2025 and bottomed at $66000.0 in Q4 2024.
  • The 5-year median for Cash & Equivalents is $2.8 million (2022), against an average of $2.8 million.
  • The largest annual shift saw Cash & Equivalents plummeted 94.88% in 2024 before it surged 11950.0% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $5.3 million in 2021, then tumbled by 92.73% to $382000.0 in 2022, then surged by 237.43% to $1.3 million in 2023, then tumbled by 94.88% to $66000.0 in 2024, then soared by 11950.0% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for PDEX's Cash & Equivalents are $8.0 million (Q4 2025), $514000.0 (Q3 2025), and $419000.0 (Q2 2025).